Phase 3 Trial of Radiotherapy With/Without Cetuximab in Head and Neck Cancer

Share this content:
Researchers are attempting to determine whether radiotherapy is more effective with or without cetuximab.
Researchers are attempting to determine whether radiotherapy is more effective with or without cetuximab.

Title: Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer1

Study Chair: Mitchell Machtay, MD, University Hospitals Seidman Cancer Center, Cleveland, Ohio

Description: For this randomized phase 3 study ClinicalTrials.gov Identifier: NCT00956007), researchers are attempting to determine whether radiotherapy is more effective with or without cetuximab among patients with locally advanced head and neck cancer.

There are 2 trial arms: in arm 1 patients will receive radiotherapy 5 days a week for 5 weeks; in arm 2 patients will receive the arm 1 therapy plus cetuximab intravenously 5 or more days before radiotherapy and 4 weeks thereafter. Researchers will discontinue treatment in the event of disease progression or unacceptable toxicity.

The primary outcome is overall survival. Secondary outcomes include toxicity, disease-free survival, and loco-regional control.

For more study information, including inclusion and exclusion criteria, study locations, and contact information, visit https://clinicaltrials.gov/ct2/show/NCT01311063.

Status: This study is open and recruiting patients as of February 9, 2017.

Cetuximab is epidermal growth factor receptor (EGFR) inhibitor approved by the U.S. Food and Drug Administration for the treatment of colorectal cancer and neck and neck cancer.

Reference

  1. Clinicaltrials.gov. A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer. NCT00956007. https://clinicaltrials.gov/ct2/show/NCT01311063. Accessed February 9, 2017.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters